Cross Country Healthcare, Inc.
CCRN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1 | $2 | $3 | $2 |
| % Growth | -33.5% | -28% | 67.2% | – |
| Cost of Goods Sold | $1 | $2 | $2 | $1 |
| Gross Profit | $0 | $0 | $1 | $0 |
| % Margin | 20.4% | 22.3% | 22.3% | 22.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Income | -$0 | $0 | $0 | $0 |
| % Margin | -1.3% | 5.6% | 9.6% | 8.3% |
| Other Income/Exp. Net | $0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$0 | $0 | $0 | $0 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$0 | $0 | $0 | $0 |
| % Margin | -1.1% | 3.6% | 6.6% | 7.9% |
| EPS | -0.44 | 2.07 | 5.09 | 3.6 |
| % Growth | -121.3% | -59.3% | 41.4% | – |
| EPS Diluted | -0.44 | 2.05 | 5.02 | 3.53 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 1.2% | 6.4% | 10% | 9.2% |